PDE 2013, Paris, France: Another Exciting Workshop for Cyclic AMP, Protein Kinase A, and Phosphodiesterases

C. A. Stratakis; J. Bertherat

doi:10.1055/s-0034-1394418

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2014; 46(12): 825-826
DOI: 10.1055/s-0034-1394418

Editorial

PDE 2013, Paris, France: Another Exciting Workshop for Cyclic AMP, Protein Kinase A, and Phosphodiesterases

C. A. Stratakis

¹Section on Endocrinology & Genetics, Program on Developmental Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, Bethesda, USA

,

J. Bertherat

²Endocrinology Department, Hôpital Cochin, AP-HP & Institut Cochin, INSERM U1016, CNRS 8104, Université Paris Descartes, Paris, France

› Author Affiliations

Abstract

Full Text

References

References
1 Stratakis CA. Cyclic AMP, protein kinase A, and phosphodiesterases: proceedings of an international workshop. Horm Metab Res 2012; 44: 713-715
2 Mantovani G, Elli FM, Spada A. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?. Horm Metab Res 2012; 44: 716-723
3 Zhang S, Kaplan FS, Shore EM. Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation. Horm Metab Res 2012; 44: 724-731
4 Bastepe M. Relative functions of Gαs and its extra-large variant XLαs in the endocrine system. Horm Metab Res 2012; 44: 732-740
5 Yu B, Ragazzon B, Rizk-Rabin M, Bertherat J. Protein kinase A alterations in endocrine tumors. Horm Metab Res 2012; 44: 741-748
6 Silve C, Clauser E, Linglart A. Acrodysostosis. Horm Metab Res 2012; 44: 749-758
7 Hussain MA, Stratakis CA, Kirschner L. Prkar1a in the regulation of insulin secretion. Horm Metab Res 2012; 44: 759-765
8 Knight WE, Yan C. Cardiac cyclic nucleotide phosphodiesterase: function, regulation, and therapeutic prospects. Horm Metab Res 2012; 44: 766-775
9 Ahmad F, Degerman E, Manganiello VC. Cyclic nucleotide phosphodiesterase 3 signaling complexes. Horm Metab Res 2012; 44: 776-785
10 Vincent P, Castro LR, Gervasi N, Guiot E, Brito M, Paupardin-Tritsch D. PDE4 control on cAMP/PKA compartmentation revealed by biosensor imaging in neurons. Horm Metab Res 2012; 44: 786-789
11 Tsai LC, Beavo JA. Regulation of adrenal steroidogenesis by the high-affinity phosphodiesterase 8 family. Horm Metab Res 2012; 44: 790-794
12 Stratakis CA, Kirschner LS. Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res 1998; 30: 456-463
13 Stratakis CA, Marx SJ. Multiple endocrine neoplasias in the era of translational medicine. Horm Metab Res 2005; 37: 343-346
14 Stratakis CA. Adrenocortical tumors, primary pigmented adrenocortical disease (PPNAD)/Carney complex, and other bilateral hyperplasias: the NIH studies. Horm Metab Res 2007; 39: 467-473
15 Boikos SA, Horvath A, Heyerdahl S, Stein E, Robinson-White A, Bossis I, Bertherat J, Carney JA, Stratakis CA. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions. Horm Metab Res 2008; 40: 347-353
16 Assié G, Jouinot A, Bertherat J. The ‘omics’ of adrenocortical tumours for personalized medicine. Nat Rev Endocrinol 2014; 10: 215-228
17 Azevedo MF, Faucz FR, Bimpaki E, Horvath A, Levy I, de Alexandre RB, Ahmad F, Manganiello V, Stratakis CA. Clinical and molecular genetics of the phosphodiesterases (PDEs). Endocr Rev 2014; 35: 195-233
18 Calebiro D, Sungkaworn T, Maiellaro I. Real-time monitoring of GPCR/cAMP signalling by FRET and single-molecule microscopy. Horm Metab Res 2014; 46: 827-832
19 Rogne M, Taskén K. Compartmentalization of cAMP signaling in adipogenesis, lipogenesis, and lipolysis. Horm Metab Res 2014; 46: 833-840
20 Weinstein LS. Role of Gsα in central regulation of energy and glucose metabolism. Horm Metab Res 2014; 46: 841-844
21 Insel PA, Wilderman A, Zhang L, Keshwani MM, Zambon AC. Cyclic AMP/PKA-promoted apoptosis: insights from studies of S49 lymphoma cells. Horm Metab Res 2014; 46: 854-862
22 Peverelli E, Giardino E, Vitali E, Treppiedi D, Lania AG, Mantovani G. Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation. Horm Metab Res 2014; 46: 845-853
23 Szarek E, Stratakis CA. Phosphodiesterases and adrenal cushing in mice and humans. Horm Metab Res 2014; 46: 863-868
24 Espiard S, Ragazzon B, Bertherat J. Protein kinase A alterations in adrenocortical tumors. Horm Metab Res 2014; 46: 869-875
25 Louiset E, Duparc C, Groussin L, Gobet F, Desailloud R, Barrande G, Reznik Y, Bertherat J, Prévost G, Lefebvre H. Abnormal sensitivity to glucagon and related peptides in primary adrenal Cushing’s syndrome. Horm Metab Res 2014; 46: 876-882
26 Basso F, Rocchetti F, Rodriguez S, Nesterova M, Cormier F, Stratakis CA, Ragazzon B, Bertherat J, Rizk-Rabin M. Comparison of the effects of PRKAR1A and PRKAR2B depletion on signaling pathways, cell growth, and cell cycle control of adrenocortical cells. Horm Metab Res 2014; 46: 883-888
27 Berthon A, Stratakis CA. From β-catenin to ARM-repeat proteins in adrenocortical disorders. Horm Metab Res 2014; 46: 889-896
28 London E, Lodish M, Keil M, Lyssikatos C, de la Luz Sierra M, Nesterova M, Stratakis CA. Not all glucocorticoid-induced obesity is the same: differences in adiposity among various diagnostic groups of Cushing syndrome. Horm Metab Res 2014; 46: 897-903